| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 7e-09 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-09 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-08 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-08 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-07 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |